Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longping V Tse

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
ACS Omega|March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan J Fritch, Thomas R Lane, et al.
Nature Immunology|June 2, 2022
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like virusesWan-Ting He, Rami Musharrafieh, Ge Song, et al.
Cell Host & Microbe|May 15, 2020
Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human AntibodiesEllen Young, Robert H Carnahan, Daniela V Andrade, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like virusesWan-Ting He, Rami Musharrafieh, Ge Song, et al.
Cell Reports|April 12, 2024
SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epitheliaRita M Meganck, Caitlin E Edwards, Michael L Mallory, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2022
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe diseasePanpan Zhou, Ge Song, Wan-Ting He, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Immunity|March 8, 2023
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly diseasePanpan Zhou, Ge Song, Hejun Liu, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Journal of Clinical Microbiology|July 21, 2021
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization AssaysAnton M Sholukh, Andrew Fiore-Gartland, Emily S Ford, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
ACS Omega|March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan J Fritch, Thomas R Lane, et al.
Nature Immunology|June 2, 2022
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like virusesWan-Ting He, Rami Musharrafieh, Ge Song, et al.
Cell Host & Microbe|May 15, 2020
Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human AntibodiesEllen Young, Robert H Carnahan, Daniela V Andrade, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like virusesWan-Ting He, Rami Musharrafieh, Ge Song, et al.
Cell Reports|April 12, 2024
SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epitheliaRita M Meganck, Caitlin E Edwards, Michael L Mallory, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2022
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe diseasePanpan Zhou, Ge Song, Wan-Ting He, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Immunity|March 8, 2023
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly diseasePanpan Zhou, Ge Song, Hejun Liu, et al.
Science (New York, N.Y.)|January 26, 2021
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Journal of Clinical Microbiology|July 21, 2021
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization AssaysAnton M Sholukh, Andrew Fiore-Gartland, Emily S Ford, et al.
Pageof 5